Evoke Pharma, Inc. (EVOK)
NASDAQ: EVOK · Real-Time Price · USD
5.07
-0.42 (-7.65%)
Dec 20, 2024, 4:00 PM EST - Market closed
Evoke Pharma Revenue
Evoke Pharma had revenue of $2.65M in the quarter ending September 30, 2024, with 69.83% growth. This brings the company's revenue in the last twelve months to $8.62M, up 100.35% year-over-year. In the year 2023, Evoke Pharma had annual revenue of $5.18M with 106.51% growth.
Revenue (ttm)
$8.62M
Revenue Growth
+100.35%
P/S Ratio
0.87
Revenue / Employee
$2,154,259
Employees
4
Market Cap
10.48M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Zhongchao | 17.41M |
Sol-Gel Technologies | 11.71M |
Immuron | 3.27M |
Lyra Therapeutics | 1.47M |
AIM ImmunoTech | 190.00K |
EVOK News
- 2 days ago - Evoke Pharma Highlights GIMOTI as a Leading Solution for Gastroparesis Treatment as Domperidone Supply Ends - GlobeNewsWire
- 18 days ago - Evoke Pharma Receives Notices of Allowance for Two Additional US Patent Applications Protecting GIMOTI® - GlobeNewsWire
- 5 weeks ago - InvestCloud to Partner with Evoke Advisors to Transform Their Digital Experience - Business Wire
- 6 weeks ago - Evoke Pharma, Inc. Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 7 weeks ago - Evoke Pharma stock surges over 100%—here's why - Invezz
- 2 months ago - Evoke Pharma to Showcase Award-Winning Research at the 2024 American College of Gastroenterology Annual Scientific Meeting - GlobeNewsWire
- 2 months ago - Evoke Pharma Announces the Appointment of Ben Smeal to the Board of Directors - GlobeNewsWire
- 2 months ago - Evoke Pharma Announces Proceeds from Existing Warrants and Board Expansion - GlobeNewsWire